1672-9188
2008 Issue 12
..............page:757
..............page:749
..............page:765-766
..............page:762-764
Comments on the global biological drugs market
YAO Zhen-Yu
YAO Zhen-Yu
..............page:758-761
Development of pharmaceutical care mode which considers patients as a center
XIA Pei-Fen;MENG Lin-Yi;WANG Fang
XIA Pei-Fen;MENG Lin-Yi;WANG Fang
..............page:754-757
..............page:750-753,757
The effect of low dose naloxone on analgesia of ketamine
LV Juan;CAI Cheng-Sen;ZHOU Chun;ZHAO Dan;ZHANG Wei;WANG Ya-Han;ZHUO Jiu-Wu;DAI Ti-Jun
LV Juan;CAI Cheng-Sen;ZHOU Chun;ZHAO Dan;ZHANG Wei;WANG Ya-Han;ZHUO Jiu-Wu;DAI Ti-Jun
..............page:746-749
Electrochemistry study about the transdermal percolation rate of paeonol from different gels in vitro
XIA Hong-Mei;HU Wen-Juan;TONG Hai-Xia;CHEN Yan-Jie
XIA Hong-Mei;HU Wen-Juan;TONG Hai-Xia;CHEN Yan-Jie
..............page:741-745
Thalidomide combined with chemotherapy in the treatment of advanced non-small cell lung cancer
CHEN Ying
CHEN Ying
..............page:736-740
The use of microecologics in the treatment of irritable bowel syndrome
MO Wen-Hui;GUO Chuan-Yong
MO Wen-Hui;GUO Chuan-Yong
..............page:722-726
..............page:716-721
Current concepts of autoimmune pancreatitis
GAO Rui;LIAO Zhuan;LU Yi;LI Zhao-Shen
GAO Rui;LIAO Zhuan;LU Yi;LI Zhao-Shen
..............page:710-715,726
Advances in canceration of chronic pancreatitis
LAI Xiao-Wei;LIAO Zhuan;LI Zhao-Shen
LAI Xiao-Wei;LIAO Zhuan;LI Zhao-Shen
..............page:705-709
..............page:前插1
The use of glycyrrhizic acid in the treatment of drug-induced liver disease
WANG Lin;HE Sheng-Hua;YANG Jing-Jing
WANG Lin;HE Sheng-Hua;YANG Jing-Jing
..............page:731-735
Progress of aminosalicylates in the treatment of inflammatory bowel disease
QU Yun-Dong;Lin Sen
QU Yun-Dong;Lin Sen
..............page:727-730